The Trump administration is shaming brand-name drugmakers who refuse to sell samples so generics can be made from their products.
KHN’s Sarah Jane Tribble explains the key elements of the Trump blueprint on CBS News’ "Red & Blue."
Anthem, one of the country’s largest insurers, has cut the reimbursement rate it pays for breast pumps by nearly half, fueling concerns that new moms — especially ones with lower incomes — will not be able to afford the pumps they need.
The Pennsylvania-based health chain Geisinger plans to offer DNA sequencing as part of regular patient care.
Guess who’s back grabbing headlines? Pharmacy benefit managers — those companies that serve as middlemen in the prescription drug pipeline.
Use Our Database For Your Reporting
Patient advocacy groups campaign to raise awareness of diseases, to fund research and to promote policies favorable to their causes on Capitol Hill and at the Food and Drug Administration. But do they represent patients or Big Pharma? Kaiser Health News has compiled and analyzed disclosures to shed light on the flow of money between the pharmaceutical industry and patient advocacy groups.
Sign Up For Our Email Newsletter
Stay informed by signing up for the KHN Morning Briefing and other emails: